abemaciclib
eli lilly
['monarche,(-monarcher)', 'monarche']
 #asco2023 monarche follow-up. adjuvant abemiciclib equally effective in patients over 66 but twice as many patients over 65 discontinued therapy due to toxicity. benefit may be retained with dose reduction and can be considered before discontinuing.
Breast med oncology, chief hem/onc @NYPBrooklyn, prof clinical med @WeillCornell, ethics/spirituality in medicine; long time NY #Jets sufferer; tweets my own